Stevanato Group S.p.A. is a global provider of primary packaging solutions and drug delivery systems for the pharmaceutical and biotechnology industries. Founded in 1949 in Italy, the company has grown from a small glass manufacturer into an integrated partner for drug developers and contract manufacturing organizations. Stevanato Group’s Lisbon headquarters coordinate R&D activities, quality management and global marketing efforts, while its operational centers span Europe, the Americas and the Asia‐Pacific region.
The company’s core business is organized into two divisions. The Pharma Systems division produces a range of high‐quality glass primary containers, including Type I borosilicate vials, cartridges and prefillable syringes, as well as elastomeric stoppers and specialized polymer components. The Engineering Systems division designs and builds automated inspection, assembly and serialization equipment that ensures product integrity and compliance with evolving regulatory standards. Through this integrated approach, Stevanato Group offers customers turnkey solutions from container design to final packaging line validation.
Stevanato Group serves a broad geographic footprint, operating manufacturing facilities in Italy, the United States, Brazil, Slovakia, the Czech Republic and China, with additional sales and support offices in Singapore and Switzerland. The company’s strategic expansion into North America and Asia reflects its commitment to providing localized service and accelerating time to market for global biopharmaceutical clients. In recent years, Stevanato has invested heavily in continuous manufacturing technologies and expanded its in‐house analytical laboratories to support advanced drug formulation studies and device testing.
Under the leadership of Group CEO Luigi Carlon, Stevanato Group continues to prioritize innovation, sustainability and regulatory excellence. The executive team, which includes experienced professionals in quality assurance, engineering and commercialization, has driven initiatives in lightweight glass production, digital traceability and carbon footprint reduction. By aligning its long‐standing expertise in glass science with cutting‐edge device engineering, Stevanato Group aims to partner with pharmaceutical companies in addressing emerging challenges such as cold chain logistics, combination therapies and personalized medicine delivery.
AI Generated. May Contain Errors.
Free STVN Stock Alerts